Vanguard Group’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.52M | Sell |
|
|||||
|
2025
Q1 | $4.9M | Sell |
|
|||||
|
2024
Q4 | $5.96M | Buy |
|
|||||
|
2024
Q3 | $5.4M | Hold |
|
|||||
|
2024
Q2 | $6.24M | Hold |
|
|||||
|
2024
Q1 | $9.47M | Sell |
|
|||||
|
2023
Q4 | $9.43M | Buy |
|
|||||
|
2023
Q3 | $1.33M | Buy |
|
|||||
|
2023
Q2 | $419K | Buy |
|
|||||
|
2023
Q1 | $616K | Buy |
|
|||||
|
2022
Q4 | $488K | Sell |
|
|||||
|
2022
Q3 | $720K | Sell |
|
|||||
|
2022
Q2 | $8.77M | Buy |
|
|||||
|
2022
Q1 | $11.5M | Buy |
|
|||||
|
2021
Q4 | $18.1M | Buy |
|
|||||
|
2021
Q3 | $24.1M | Sell |
|
|||||
|
2021
Q2 | $28M | Buy |
|
|||||
|
2021
Q1 | $12.4M | Buy |
|
|||||
|
2020
Q4 | $6.33M | Buy |
|
|||||
|
2020
Q3 | $1.36M | Buy |
|
|||||
|
2020
Q2 | $615K | Sell |
|
|||||
|
2020
Q1 | $531K | Buy |
|
|||||
|
2019
Q4 | $831K | Hold |
|
|||||
|
2019
Q3 | $1.29M | Buy |
|
|||||
|
2019
Q2 | $868K | Buy |
|
|||||
|
2019
Q1 | $1.49M | Buy |
|
|||||
|
2018
Q4 | $1.16M | Buy |
|
|||||
|
2018
Q3 | $373K | Buy |
|
|||||
|
2018
Q2 | $247K | Buy |
|
|||||
|
2018
Q1 | $163K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $65K | Buy |
|
|||||
|
2017
Q2 | $69K | Sell |
|
|||||
|
2017
Q1 | $77K | Buy |
|
|||||
|
2016
Q4 | $140K | Buy |
|